Advertisement

More articles from Priority Briefs

  • Early-Life Microbiota Restricts Colonic Tumorigenesis
    Akihito Harusato, Emilie Viennois, Lucie Etienne-Mesmin, Shingo Matsuyama, Hirohito Abo, Satoru Osuka, Nicholas W. Lukacs, Yuji Naito, Yoshito Itoh, Jian-Dong Li, Didier Merlin, Andrew T. Gewirtz, Timothy L. Denning
    Cancer Immunology Research Apr 2019, 7 (4) 544-551; DOI: 10.1158/2326-6066.CIR-18-0444
  • AML Targeting by Cytotoxic Delta One T Cells
    Biagio Di Lorenzo, André E. Simões, Francisco Caiado, Paola Tieppo, Daniel V. Correia, Tânia Carvalho, Maria Gomes da Silva, Julie Déchanet-Merville, Ton N. Schumacher, Immo Prinz, Haakan Norell, Sarina Ravens, David Vermijlen, Bruno Silva-Santos
    Cancer Immunology Research Apr 2019, 7 (4) 552-558; DOI: 10.1158/2326-6066.CIR-18-0647
  • DNA Neoantigen Vaccines Generate CD8 T-cell Immunity
    Elizabeth K. Duperret, Alfredo Perales-Puchalt, Regina Stoltz, Hiranjith G.H., Nitin Mandloi, James Barlow, Amitabha Chaudhuri, Niranjan Y. Sardesai, David B. Weiner
    Cancer Immunology Research Feb 2019, 7 (2) 174-182; DOI: 10.1158/2326-6066.CIR-18-0283
  • Birinapant Enhances CAR T-cell Efficacy
    Jessica Michie, Paul A. Beavis, Andrew J. Freeman, Stephin J. Vervoort, Kelly M. Ramsbottom, Vignesh Narasimhan, Emily J. Lelliott, Najoua Lalaoui, Robert G. Ramsay, Ricky W. Johnstone, John Silke, Phillip K. Darcy, Ilia Voskoboinik, Conor J. Kearney, Jane Oliaro
    Cancer Immunology Research Feb 2019, 7 (2) 183-192; DOI: 10.1158/2326-6066.CIR-18-0428
  • S100A9 Induces Multiple Myeloma Cell Survival
    Kim De Veirman, Nathan De Beule, Ken Maes, Eline Menu, Elke De Bruyne, Hendrik De Raeve, Karel Fostier, Jérôme Moreaux, Alboukadel Kassambara, Dirk Hose, Roy Heusschen, Helena Eriksson, Karin Vanderkerken, Els Van Valckenborgh
    Cancer Immunology Research Oct 2017, 5 (10) 839-846; DOI: 10.1158/2326-6066.CIR-17-0192
  • PDT and Immunotherapy of Mutated Tumors
    Jan Willem Kleinovink, Marieke F. Fransen, Clemens W. Löwik, Ferry Ossendorp
    Cancer Immunology Research Oct 2017, 5 (10) 832-838; DOI: 10.1158/2326-6066.CIR-17-0055
  • Benefit of Pembrolizumab Following Ipilimumab
    Amanda Shreders, Richard Joseph, Chengwei Peng, Fei Ye, Shilin Zhao, Igor Puzanov, Jeffrey A. Sosman, Douglas B. Johnson
    Cancer Immunology Research Jul 2016, 4 (7) 569-573; DOI: 10.1158/2326-6066.CIR-15-0281
  • Drivers of Non–T-cell-Inflamed Bladder Cancer
    Randy F. Sweis, Stefani Spranger, Riyue Bao, Gladell P. Paner, Walter M. Stadler, Gary Steinberg, Thomas F. Gajewski
    Cancer Immunology Research Jul 2016, 4 (7) 563-568; DOI: 10.1158/2326-6066.CIR-15-0274
  • Immunohistochemical Detection of Membrane PD-L1
    Kathleen M. Mahoney, Heather Sun, Xiaoyun Liao, Ping Hua, Marcella Callea, Edward A. Greenfield, F. Stephen Hodi, Arlene H. Sharpe, Sabina Signoretti, Scott J. Rodig, Gordon J. Freeman
    Cancer Immunology Research Dec 2015, 3 (12) 1308-1315; DOI: 10.1158/2326-6066.CIR-15-0116
  • PD-1 and PD-L1 in RCC with Sarcomatoid Differentiation
    Richard W. Joseph, Sherri Z. Millis, Estrella M. Carballido, David Bryant, Zoran Gatalica, Sandeep Reddy, Alan H. Bryce, Nicholas J. Vogelzang, Melissa L. Stanton, Erik P. Castle, Thai H. Ho
    Cancer Immunology Research Dec 2015, 3 (12) 1303-1307; DOI: 10.1158/2326-6066.CIR-15-0150

Pages